McAdory John Bearden bought ONCY
June 1, 2026 · Form 4 insider transaction
McAdory John Bearden bought 145,000 shares of Oncolytics Biotech Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
145,000
Price
$0.00
Total value
N/A
InsiderMcAdory John Bearden
Role—
SecurityStock Option
Transaction codeA: Grant or award
Transaction dateJune 1, 2026
Filing dateJune 3, 2026
Shares owned after145,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Capital Market on the date of grant, June 1, 2026.; The stock option vests in three equal annual installments with the first tranche vesting on June 1, 2027, subject to the Reporting Person's continued service or employment, as applicable, on each such vesting date.